Minerva Advisors’s ImmuCell ICCC Stock Holding History
Bought
Maintained
Sold
Other funds holding ICCC
CAM
BL
SRC
EFMC
OMC
Minerva Advisors's ICCC Position: Q2 2023 in Review
Minerva Advisors sold out of ImmuCell (ICCC) in Q2 2023, closing a stake of 11,958 shares — an estimated $61.1K sold.
Minerva Advisors first reported a position in ICCC in Q3 2015 and held it in 31 quarters. The position peaked at $121K in Q3 2018. 31 funds tracked by Wall St. Rank hold ICCC as of Q2 2023.
- Minerva Advisors reported no remaining ImmuCell position as of Q2 2023 after selling out during the quarter.
- Minerva Advisors sold 11,958 ImmuCell shares in Q2 2023, an estimated $61.1K.
- Minerva Advisors first reported a position in ImmuCell in Q3 2015 and held it in 31 quarters.
- Minerva Advisors's ImmuCell position peaked at $121K in Q3 2018.
- 31 funds tracked by Wall St. Rank held ImmuCell as of Q2 2023.
Based on Minerva Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.